metastatic/advanced hepatocellular cancer (mHCC) | |
lung cancer : non small cell (NSCLC) | |
pralsetinib | ARROW |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -